Charlotte A. Bäuml
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Charlotte A. Bäuml has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Adam James Moeser
Michigan State University
1 shared publication - Adrian M. Piliponsky
Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Washington, United States of America; Departments of Pediatrics,; Pathology and; Global Health, University of Washington School of Medicine, Seattle, Washington, United States of America
1 shared publication - Albert J. Seo
Center for Immunity and Immunotherapies, Seattle Children’s Research Institute, Seattle, Washington, USA
1 shared publication - Alyssa M. Brokaw
Department of Global Health, University of Washington, Seattle, Washington, USA
1 shared publication - Anna Furuta
Department of Global Health, University of Washington, Seattle, Washington, USA
1 shared publication - Austyn Orvis
Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle, Washington, USA
1 shared publication
Latest Publications
- Open Access
- 17 October 2022
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 132 (20)
Mast cell–derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections
Invasive bacterial infections remain a major cause of human morbidity. Group B streptococcus (GBS) are Gram-positive bacteria that cause invasive infections in humans. Here, we show that factor XIIIA–deficient (FXIIIA-deficient) female mice exhibited significantly increased susceptibility to GBS infections. Additionally, female WT mice had increased levels of FXIIIA and were more resistant to GBS infection compared with isogenic male mice. We observed that administration of exogenous FXIIIA to male mice increased host resistance to GBS infection. Conversely, administration of a FXIIIA transglutaminase inhibitor to female mice decreased host resistance to GBS infection. Interestingly, male gonadectomized mice exhibited decreased sensitivity to GBS infection, suggesting a role for gonadal androgens in host susceptibility. FXIIIA promoted GBS entrapment within fibrin clots by crosslinking fibronectin with ScpB, a fibronectin-binding GBS surface protein. Thus, ScpB-deficient GBS exhibited decreased entrapment within fibrin clots in vitro and increased dissemination during systemic infections. Finally, using mice in which FXIIIA expression was depleted in mast cells, we observed that mast cell–derived FXIIIA contributes to host defense against GBS infection. Our studies provide insights into the effects of sexual dimorphism and mast cells on FXIIIA expression and its interactions with GBS adhesins that mediate bacterial dissemination and pathogenesis.
- 17 October 2022
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 132 (20)
Open AccessMast cell–derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections
Invasive bacterial infections remain a major cause of human morbidity. Group B streptococcus (GBS) are Gram-positive bacteria that cause invasive infections in humans. Here, we show that factor XIIIA–deficient (FXIIIA-deficient) female mice exhibited significantly increased susceptibility to GBS infections. Additionally, female WT mice had increased levels of FXIIIA and were more resistant to GBS infection compared with isogenic male mice. We observed that administration of exogenous FXIIIA to male mice increased host resistance to GBS infection. Conversely, administration of a FXIIIA transglutaminase inhibitor to female mice decreased host resistance to GBS infection. Interestingly, male gonadectomized mice exhibited decreased sensitivity to GBS infection, suggesting a role for gonadal androgens in host susceptibility. FXIIIA promoted GBS entrapment within fibrin clots by crosslinking fibronectin with ScpB, a fibronectin-binding GBS surface protein. Thus, ScpB-deficient GBS exhibited decreased entrapment within fibrin clots in vitro and increased dissemination during systemic infections. Finally, using mice in which FXIIIA expression was depleted in mast cells, we observed that mast cell–derived FXIIIA contributes to host defense against GBS infection. Our studies provide insights into the effects of sexual dimorphism and mast cells on FXIIIA expression and its interactions with GBS adhesins that mediate bacterial dissemination and pathogenesis.